Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Morrey

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
The Journal of Infectious Diseases|May 4, 2013
Fatal neurological respiratory insufficiency is common among viral encephalitidesHong Wang, Venkatraman Siddharthan, Kyle K Kesler, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2009
Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in miceDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
Antiviral Chemistry & Chemotherapy|April 13, 2004
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidineDale L Barnard, Valerie D Hubbard, Jared Burton, et al.
Antiviral Research|July 17, 2010
Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in miceDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
Antiviral Research|August 27, 2011
Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virusJustin G Julander, Joe Hagloch, Scott Latimer, et al.
Virology|October 27, 2009
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoCraig W Day, Ralph Baric, Sui Xiong Cai, et al.
Antiviral Research|March 16, 2010
Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster modelJustin G Julander, Ashok K Jha, Jung-Ae Choi, et al.
Antiviral Research|June 16, 2004
Modeling hamsters for evaluating West Nile virus therapiesJohn D Morrey, Craig W Day, Justin G Julander, et al.
Antiviral Research|October 9, 2008
Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: importance of liposomal delivery and CpG motifsBrian B Gowen, Jeff Fairman, Steven Dow, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201R W Sidwell, D F Smee, J H Huffman, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|May 4, 2013
Fatal neurological respiratory insufficiency is common among viral encephalitidesHong Wang, Venkatraman Siddharthan, Kyle K Kesler, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2009
Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in miceDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
Antiviral Chemistry & Chemotherapy|April 13, 2004
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidineDale L Barnard, Valerie D Hubbard, Jared Burton, et al.
Antiviral Research|July 17, 2010
Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in miceDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
Antiviral Research|August 27, 2011
Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virusJustin G Julander, Joe Hagloch, Scott Latimer, et al.
Virology|October 27, 2009
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoCraig W Day, Ralph Baric, Sui Xiong Cai, et al.
Antiviral Research|March 16, 2010
Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster modelJustin G Julander, Ashok K Jha, Jung-Ae Choi, et al.
Antiviral Research|June 16, 2004
Modeling hamsters for evaluating West Nile virus therapiesJohn D Morrey, Craig W Day, Justin G Julander, et al.
Antiviral Research|October 9, 2008
Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: importance of liposomal delivery and CpG motifsBrian B Gowen, Jeff Fairman, Steven Dow, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201R W Sidwell, D F Smee, J H Huffman, et al.
Pageof 14